150 related articles for article (PubMed ID: 7962424)
1. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.
Schoot DC; Harlin J; Shoham Z; Mannaerts BM; Lahlou N; Bouchard P; Bennink HJ; Fauser BC
Hum Reprod; 1994 Jul; 9(7):1237-42. PubMed ID: 7962424
[TBL] [Abstract][Full Text] [Related]
2. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
[TBL] [Abstract][Full Text] [Related]
3. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism.
Shoham Z; Mannaerts B; Insler V; Coelingh-Bennink H
Fertil Steril; 1993 Apr; 59(4):738-42. PubMed ID: 8458489
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
[TBL] [Abstract][Full Text] [Related]
5. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
[TBL] [Abstract][Full Text] [Related]
6. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
van Heusden AM; Coelingh Bennink HJ; Fauser BC
Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
[TBL] [Abstract][Full Text] [Related]
7. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
Schoot DC; Coelingh Bennink HJ; Mannaerts BM; Lamberts SW; Bouchard P; Fauser BC
J Clin Endocrinol Metab; 1992 Jun; 74(6):1471-3. PubMed ID: 1592896
[TBL] [Abstract][Full Text] [Related]
8. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
Karnitis VJ; Townson DH; Friedman CI; Danforth DR
J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
[TBL] [Abstract][Full Text] [Related]
10. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development.
Hohmann FP; Laven JS; de Jong FH; Eijkemans MJ; Fauser BC
Hum Reprod; 2001 May; 16(5):846-54. PubMed ID: 11331627
[TBL] [Abstract][Full Text] [Related]
11. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.
Mannaerts B; Fauser B; Lahlou N; Harlin J; Shoham Z; Bennink HC; Bouchard P
Fertil Steril; 1996 Feb; 65(2):406-10. PubMed ID: 8566271
[TBL] [Abstract][Full Text] [Related]
12. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
Hohmann FP; Laven JS; de Jong FH; Fauser BC
Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development.
Welt CK; Smith ZA; Pauler DK; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2531-7. PubMed ID: 11397851
[TBL] [Abstract][Full Text] [Related]
14. Effect of luteinizing hormone on follicle stimulating hormone-activated paracrine signalling in rat ovary.
Smyth CD; Miró F; Howles CM; Hillier SG
Hum Reprod; 1995 Jan; 10(1):33-9. PubMed ID: 7745066
[TBL] [Abstract][Full Text] [Related]
15. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
[TBL] [Abstract][Full Text] [Related]
16. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.
Bry-Gauillard H; Larrat-Ledoux F; Levaillant JM; Massin N; Maione L; Beau I; Binart N; Chanson P; Brailly-Tabard S; Hall JE; Young J
J Clin Endocrinol Metab; 2017 Apr; 102(4):1102-1111. PubMed ID: 28324034
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.
Eldar-Geva T; Robertson DM; Cahir N; Groome N; Gabbe MP; Maclachlan V; Healy DL
J Clin Endocrinol Metab; 2000 Feb; 85(2):607-13. PubMed ID: 10690863
[TBL] [Abstract][Full Text] [Related]
19. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D
Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
[TBL] [Abstract][Full Text] [Related]
20. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
